International Conference on Neuroscience, Brain Mapping and Therapeutics ICNBMT on December 02-03, 2026 in Tokyo, Japan

Neuroscience, Brain Mapping and Therapeutics
Imaging Brain Networks in Neurodegenerative Diseases
Neurosurgery (e.g. Image Guided Therapy/intervention, brain tumors and intraoperative navigation, nanoneurosurgery, stereotactic radiosurgery, minimally invasive therapy, vascular neurosurgery, functional neurosurgery, neurotrauma/military medicine, surgical simulation)
Neurology (e.g. Movement Disorders, Neurodegenerative Diseases, Neurooncology, Neuromodulation, epilepsy, autism, brain and spinal cord function)
Psychiatry (e.g. medical imaging for psychiatric conditions such as schizophrenia, depression, PTSD)
Radiology (e.g. fMRI, PET, Nuclear medicine, MR SPEC, MR-PET, DTI, CT-PET, Focused Ultrasound, SQUID MRI, ultra high/low MRI)
Neuroscience (e.g. stem cell, molecular neuroscience, image guided mapping of genes, proteomics, genomics, neurophysiology)
Neuroengineering (e.g. biomaterial and tissue engineering, human brain Machine Interface, brain and spinal cord devices, nanomedicine, extraterrestrial/space medicine and clinical practice, software engineering, electrical and material engineering, aeronautic engineering/space medicine and Radiation Physics/Oncology as well as robotics)
Nano-Bio-Electronics (e.g. integration of Stem cell/cellular therapy with nanotechnology, medical devices and imaging)
Spinal Cord (e.g. regeneration, stem cell, imaging, implants and biologics and imaging)
Policy (e.g. healthcare policy issues that affect the treatment delivery, and usage of certain devices/drugs/imaging technologies, FDA regulations and reimbursements, federal and regional regulation impacting healthcare delivery and research funding)